---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-000027"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2026-01-02T23:59:59+00:00"
generated_at: "2026-05-16T11:47:24.099900+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Sonoma Pharmaceuticals grants annual equity to executives and directors

## Summary
- Non-employee directors each received 10,000 options at $3.68, vesting in 3 equal annual tranches.
- CEO Amy Trombly received 10,000 RSUs vesting on the third anniversary or upon change of control.
- CFO Jerry Dvonch received 5,000 RSUs vesting on the third anniversary or upon change of control.

## SEC filing metadata
- accession: 0001683168-26-000027
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2026-01-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316826000027/0001683168-26-000027-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316826000027/sonoma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-000027
- JSON: https://secwatch.observer/filing/0001683168-26-000027.json
- Plain text: https://secwatch.observer/filing/0001683168-26-000027.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.